Abstract

Cholesterol efflux capacity associates strongly and negatively with the incidence and prevalence of human CVD. We investigated the relationships of HDL’s size and protein cargo with its cholesterol efflux capacity using APOB-depleted serum and HDLs isolated from five inbred mouse strains with different susceptibilities to atherosclerosis. Like humans, mouse HDL carried >70 proteins linked to lipid metabolism, the acute-phase response, proteinase inhibition, and the immune system. HDL’s content of specific proteins strongly correlated with its size and cholesterol efflux capacity, suggesting that its protein cargo regulates its function. Cholesterol efflux capacity with macrophages strongly and positively correlated with retinol binding protein 4 (RBP4) and PLTP, but not APOA1. In contrast, ABCA1-specific cholesterol efflux correlated strongly with HDL’s content of APOA1, APOC3, and APOD, but not RBP4 and PLTP. Unexpectedly, APOE had a strong negative correlation with ABCA1-specific cholesterol efflux capacity. Moreover, the ABCA1-specific cholesterol efflux capacity of HDL isolated from APOE-deficient mice was significantly greater than that of HDL from wild-type mice. Our observations demonstrate that the HDL-associated APOE regulates HDL’s ABCA1-specific cholesterol efflux capacity. These findings may be clinically relevant because HDL’s APOE content associates with CVD risk and ABCA1 deficiency promotes unregulated cholesterol accumulation in human macrophages.

Highlights

  • Cholesterol efflux capacity associates strongly and negatively with the incidence and prevalence of human CVD

  • To test the hypothesis that the HDLs in different strains of mice have different protein cargos that affect size and function, we used shotgun proteomics to analyze HDL isolated from the plasma of five inbred mouse strains that differed in atherosclerosis susceptibility

  • We examined the relationships between macrophage cholesterol efflux capacity, ABCA1-specific cholesterol efflux capacity, and macrophage ABCA1-specific cholesterol efflux capacity using serum HDL from all five strains of mice (14 animals)

Read more

Summary

Introduction

Cholesterol efflux capacity associates strongly and negatively with the incidence and prevalence of human CVD. HDL’s content of specific proteins strongly correlated with its size and cholesterol efflux capacity, suggesting that its protein cargo regulates its function. Our observations demonstrate that the HDL-associated APOE regulates HDL’s ABCA1-specific cholesterol efflux capacity. These findings may be clinically relevant because HDL’s APOE content associates with CVD risk and ABCA1 deficiency promotes unregulated cholesterol accumulation in human macrophages.—Pamir, N., P. Two drugs, CETP inhibitors and niacin, that elevate HDL-C levels by different mechanisms, failed to reduce CVD risk in statin-treated humans with established atherosclerosis [2, 3] These observations indicate that raising HDL-C levels does not necessarily improve HDL’s cardioprotective functions.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call